Working on both sides of the bench-to-bedside translation – turning biological discovery into patient care – is a privilege and my passion.
Where I see patients (3)
Selected research
-
Clinical Targeted Next-Generation Panel Sequencing Reveals MYC Amplification Is a Poor Prognostic Factor in Osteosarcoma.
JCO precision oncology
-
GATOR2-dependent mTORC1 activity is a therapeutic vulnerability in FOXO1 fusion-positive rhabdomyosarcoma.
JCI insight
-
Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood Cancer.
JCO precision oncology
Contact me
Soothing the soul
Our music therapy program nurtures patients with bedside serenades, rap workshops and more.
Find out more